Speaker illustration

Associate Professor Zanfina Ademi

Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne (Australia)

Member of:

European Society of Cardiology

Zanfina Ademi is Associate Professor of Health Economics and Outcome Research and Deputy Director at the Centre of Cardiovascular Research and Education in Therapeutics (CCRET) in the School of Public Health and Preventive Medicine at Monash University. Zanfina leads three streams within Monash Outcomes Research and health Economics (MORE) Unit: 1. Cardiovascular Disease and Diabetes 2. Epilepsy and 3. Healthy Lifestyle in Preconception, Pregnancy and Postpartum. Zanfina specialises in Health Technology Assessments (HTAs), economic evaluations alongside clinical trials and clinical registries and decision health economic modelling. Zanfina has worked in a number of universities, including in Australia, Finland and Switzerland. She has completed a number of funded research projects that provided evidence on cost-effectiveness, enabling key decision makers (governments, payers) to enact effective healthcare funding across the world.

Population genomic screening of all young adults in Australia to detect familial hypercholesterolemia: a cost-effectiveness analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in Primary Care

Session: Highlights from the Young in risk factors revisited

Thumbnail

Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Health Economics

Session: Global and National Trends in Cardiovascular Disease Mortality, Quality of Care and Economics

Thumbnail

Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?

Event: ESC Asia with APSC & AFC 2020

Topic: Health Economics

Session: Abstract Programme

Thumbnail

This platform is supported by

logo Novo Nordisk